Cargando…
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
BACKGROUND: Osteosarcoma is the most common malignant solid tumor that affects bones, however, survival rates of patients with relapsed osteosarcoma have not improved in the last 30 years. Oncolytic virotherapy, which uses viruses designed to selectively replicate in cancer cells, has emerged as a p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978281/ https://www.ncbi.nlm.nih.gov/pubmed/33737338 http://dx.doi.org/10.1136/jitc-2020-001703 |